Lv1
48 积分 2024-10-15 加入
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
5小时前
已完结
Lenvatinib non-inferior to sorafenib for hepatocellular carcinoma
5小时前
已完结
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
4天前
已完结
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
18天前
已完结
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
21天前
已完结
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
21天前
已完结
EEG based multi-class seizure type classification using convolutional neural network and transfer learning
1个月前
已完结
Automated diagnosis of epilepsy from EEG signals using ensemble learning approach
1个月前
已完结
Tumour evolution in hepatocellular carcinoma
2个月前
已完结
Ru Single-Atom Nanozymes Targeting ROS-Ferroptosis Pathways for Enhanced Endometrial Regeneration in Intrauterine Adhesion Therapy
2个月前
已完结
皖公网安备34019202002308
